These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 22806266)
41. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition. Jacob S; Nair AB; Al-Dhubiab BE J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522 [TBL] [Abstract][Full Text] [Related]
42. Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate. Balaguer-Fernández C; Padula C; Femenía-Font A; Merino V; Santi P; López-Castellano A Drug Deliv; 2010 Feb; 17(2):83-91. PubMed ID: 20067437 [TBL] [Abstract][Full Text] [Related]
43. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. Bhatia A; Kumar R; Katare OP J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383 [TBL] [Abstract][Full Text] [Related]
44. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies. Ammar HO; Mohamed MI; Tadros MI; Fouly AA AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503 [TBL] [Abstract][Full Text] [Related]
45. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. El-Menshawe SF; Hussein AK Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880 [TBL] [Abstract][Full Text] [Related]
46. Designing Optimum Drug Delivery Systems Using Machine Learning Approaches: a Prototype Study of Niosomes. Shahiwala AF; Qawoogha SS; Faruqui N AAPS PharmSciTech; 2023 Apr; 24(4):94. PubMed ID: 37012582 [TBL] [Abstract][Full Text] [Related]
47. Proniosomes as drug carriers. Sankar V; Ruckmani K; Durga S; Jailani S Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875 [TBL] [Abstract][Full Text] [Related]
48. Exploring the co-loading of lidocaine chemical forms in surfactant/phospholipid vesicles for improved skin delivery. Caddeo C; Valenti D; Nácher A; Manconi M; Fadda AM J Pharm Pharmacol; 2015 Jul; 67(7):909-17. PubMed ID: 25648182 [TBL] [Abstract][Full Text] [Related]
49. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation. Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274 [TBL] [Abstract][Full Text] [Related]
50. Development and optimization of boswellic acid-loaded proniosomal gel. Mehta M; Dureja H; Garg M Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869 [TBL] [Abstract][Full Text] [Related]
51. Development, manufacture and characterization of niosomes for the delivery for nevirapine. Witika BA; Walker RB Pharmazie; 2019 Feb; 74(2):91-96. PubMed ID: 30782257 [TBL] [Abstract][Full Text] [Related]
52. Niosomes as Nano-Delivery Systems in the Pharmaceutical Field. Cerqueira-Coutinho C; Dos Santos EP; Mansur CR Crit Rev Ther Drug Carrier Syst; 2016; 33(2):195-212. PubMed ID: 27651102 [TBL] [Abstract][Full Text] [Related]
53. [Effects of liposomes formulation and preparation method on the stability of acyclovir palmitate liposomes]. Liu H; Tang R; He XX; Zhang Y Yao Xue Xue Bao; 2002 Jul; 37(7):563-6. PubMed ID: 12914330 [TBL] [Abstract][Full Text] [Related]
54. Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process. González-Rodríguez ML; Arroyo CM; Cózar-Bernal MJ; González-R PL; León JM; Calle M; Canca D; Rabasco AM Drug Dev Ind Pharm; 2016 Oct; 42(10):1683-94. PubMed ID: 26981839 [TBL] [Abstract][Full Text] [Related]
55. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729 [TBL] [Abstract][Full Text] [Related]
56. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. El-Ridy MS; Abdelbary A; Essam T; El-Salam RM; Kassem AA Drug Dev Ind Pharm; 2011 Dec; 37(12):1491-508. PubMed ID: 21707323 [TBL] [Abstract][Full Text] [Related]
57. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization. Moghassemi S; Hadjizadeh A; Hakamivala A; Omidfar K AAPS PharmSciTech; 2017 Jan; 18(1):34-41. PubMed ID: 27502406 [TBL] [Abstract][Full Text] [Related]
58. Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. Manconi M; Valenti D; Sinico C; Lai F; Loy G; Fadda AM Int J Pharm; 2003 Jul; 260(2):261-72. PubMed ID: 12842345 [TBL] [Abstract][Full Text] [Related]
59. Preparation and characterization of bolaform surfactant vesicles. Muzzalupo R; Trombino S; Iemma F; Puoci F; La Mesa C; Picci N Colloids Surf B Biointerfaces; 2005 Dec; 46(2):78-83. PubMed ID: 16257519 [TBL] [Abstract][Full Text] [Related]
60. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Abdelkader H; Alani AW; Alany RG Drug Deliv; 2014 Mar; 21(2):87-100. PubMed ID: 24156390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]